Trospium and cognition in patients with late onset Alzheimer disease

Journal of Nutrition, Health and Aging

Volumn 13, Issue 8, 2009, Pages 672-676

  Isik, Ahmet Turan ^a   Celik, T ^a   Bozoglu, E ^a   Doruk, H ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Alzheimer's disease; Elderly; Galantamine; Trospium; Urge incontinence

Indexed keywords

GALANTAMINE; TROSPIUM CHLORIDE;

ABDOMINAL PAIN; AGED; ALZHEIMER DISEASE; ARTICLE; BLURRED VISION; CENTRAL NERVOUS SYSTEM; COGNITION; CONSTIPATION; CONTROLLED STUDY; DEMENTIA; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; FATIGUE; FEMALE; GERIATRIC ASSESSMENT; GERIATRIC PATIENT; GLOBAL PERCEPTION INDEX; HUMAN; LIPOPHILICITY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NOCTURIA; PATIENT SATISFACTION; PATIENT SATISFACTION QUESTION; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SOMNOLENCE; TREATMENT DURATION; URGE INCONTINENCE; XEROSTOMIA;

EID: 70350490539     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12603-009-0196-5     Document Type: Article

References (27)

1. Ritchie K, Kildea D: Is senile dementia "age-related" or "ageing related"?-evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 1995;346:931-934.
2. Fantl JA, Newman DK, Colling J: Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guideline, No.2, 1996 Update,AHCPR Pub. No. 96-0682. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research, March 1996.
3. Wagg A, Cohen M: Medical therapy for the overactive bladder in the elderly. Age Ageing 2002; 31: 241-246 (Pubitemid 34905626)
4. Campbell A, Reinken J, McCosh L: Incontinence in the elderly: prevalence and prognosis. Age Ageing 1985; 14:65-70.
5. Ouslander JG: Management of overactive bladder. N Engl J Med 2004; 350:786-799.
6. Kay GG, Abou-Donia MB, Messer WS et al.: Antimuscarinic Drugs for Overactive Bladder and Their Potential Effects on Cognitive Function in Older Patients.J Am Geriatr Soc, 2005;53:2195-2201.
7. Kopelman MD:The cholinergic neurotransmitter system in human memory and dementia: A review. QJ Exp Psychol A. 1986; 38:535-573.
8. Wilkinson DG, Francis PT, Schwam E et al.:Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy, Drugs Aging 2004; 21:453-478. (Pubitemid 38736890)
9. Sink KM, Thomas J, Xu H et al.: Dual use of baldder anticholinergics and Cholinesterase inhibitors:Long-Term functional and cognitive outcomes. J Am Geriatr Soc, 2008;56:847-853. (Pubitemid 351652414)
10. Samochocki M, Hoffle A, Fehrenbacher A et al: Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine Receptors. JPET 2003;305:1024-1036. (Pubitemid 36617980)
11. Staskin DR: Overactive Bladder in the Elderly A Guide to Pharmacological Management. Drugs Aging 2005; 22: 1013-1028. (Pubitemid 41821440)
12. Rovner ES: Trospium chloride in the management of overactive bladder. Drugs 2004; 64: 2433-2446. (Pubitemid 39472630)
13. Rudy D, Cline K, Harris R et al.: Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatment BJU Int 2006; 97:540-546.
14. Isik AT, Cankurtaran M, Bozoglu E et al.: Is there 'any relation between insulin resistance and cognitive function in the elderly? Int Psychogeriatr 2007;19:745-756.
15. Folstein MF, Folstein SE, McHugh PR:Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res. 1975;12:189-198.
16. Ertan T, Eker E: Reliability, validity, and factor structure of the geriatric depression scale in Turkish elderly: are there different factor structures for different cultures? Int Psychogeriatr. 2000;12:163-172
17. Mahoney FI, Barthel DW: Functional evaluation: the Barthel Index. Md State Med J 1965;14:61-65.
18. McKhann G, Drachman D, Folstein M et al.: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 4:939-944. (Pubitemid 14076461)
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: 4th ed. (DSM-IV), Washington (DC): The Association; 1994
20. Kathryn L. Burgio, Patricia S. et al.: Global Ratings of Patient Satisfaction and Perceptions of Improvement With Treatment for Urinary Incontinence: Validation of Three Global Patient Ratings. Neurourology and Urodynamics 2006; 25:411-417
21. Scheife R, Takeda M: Central Nervous System Safety of Anticholinergic Drugs for the Treatment of Overactive Bladder in the Elderly Clin Ther. 2005; 27:144-153
22. Goepel M, Steinwachs KC: How do medications used to treat urinary incontinence affect the cerebral function of the elderly? Urologe A 2007;46:387-392.
23. Madersbacher H: Oral anticholinergics in overactive bladder, Urologe A 2006;45:830-834
24. Rudy D, Cline K, Harris R, et al: Multicenter Phase III trial studying trospium chloride in patients with overactive bladder. Urology 2006; 67: 275-280. (Pubitemid 43189841)
25. Zinner N, Gittelman M, Harris R, et al: Trospium chloride improves overactive bladder symptoms: a multicenter Phase III trial. J Urol 2004:171: 2311-2315. (Pubitemid 38625460)
26. Dmochowski RR, Sand PK, Zinner NR, Staskin DR: Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study. Urology 2008; 71: 449-454.
27. Andersson KE: Changes in bladder tone during filling: Pharmacological aspects. Scand J Urol Nephrol Suppl 1999; 201:67-72.